Super High-Pressure Balloon Versus Intravascular Lithotripsy for Severely Calcified Coronary Lesions: The ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions (ISAR-CALC) 2 Randomized Trial

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The ISAR-CALC 2 trial is an investigator-initiated, prospective, randomized, multicenter, assessors-blind, open-label other clinical investigation. The objective of this trial is to investigate final angiographic minimal lumen diameter (MLD) following a strategy of super high-pressure balloon (OPN NC) versus intravascular lithotripsy (IVL) for drug-eluting stent (DES) implantation in severely calcified coronary lesions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age above 18 years and able to give consent

• Persistent angina despite medical therapy and/or evidence of inducible ischemia

• De-novo lesion in a native coronary artery

• Target reference vessel diameter or intended stent diameter ≥2.50 or ≤4.00 mm by visual estimation

• Severe calcification of the target lesion as determined by visual estimation at coronary angiography

• Unsuccessful lesion preparation with standard non-compliant balloon (\< 30% reduction of baseline diameter stenosis at maximal pressure)

• Written informed consent.

Locations
Other Locations
Germany
Herz- und Diabeteszentrum NRW Universitätsklinikum der Ruhr-Universität Bochum
RECRUITING
Bad Oeynhausen
Universitätsklinikum Frankfurt
RECRUITING
Frankfurt Am Main
MEDICLIN Herzzentrum Lahr
RECRUITING
Lahr
Deutsches Herzzentrum Muenchen
RECRUITING
München
Contact Information
Primary
Tobias Rheude, MD
rheude@dhm.mhn.de
+49 89 1218 2985
Time Frame
Start Date: 2022-12-01
Estimated Completion Date: 2024-09-01
Participants
Target number of participants: 80
Treatments
Experimental: Super high-pressure balloon (OPN NC)
Patients will be treated with a Super High Pressure percutaneous transluminal coronary angioplasty (PTCA) Balloon (OPN NC).
Experimental: Intravascular lithotripsy (IVL)
Patients will be treated with intravascular lithotripsy (IVL).
Sponsors
Collaborators: Abbott Medical Devices, SIS Medical AG
Leads: Deutsches Herzzentrum Muenchen

This content was sourced from clinicaltrials.gov

Similar Clinical Trials